| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A common promoter variant of the gene encoding cyclooxygenase-1 (PTGS1) is related to decreased incidence of myocardial infarction in patients with coronary artery disease
|
Licis, Normunds
|
|
2011
|
127 |
6 |
p. 600-602
3 p.
|
artikel
|
| 2 |
A systematic review of rivaroxaban versus enoxaparin in the prevention of venous thromboembolism after hip or knee replacement
|
Turun, Song
|
|
2011
|
127 |
6 |
p. 525-534
10 p.
|
artikel
|
| 3 |
Bleeding response induced by anti-thrombotic doses of a phosphoinositide 3-kinase (PI3K)-β inhibitor in mice
|
Bird, J. Eileen
|
|
2011
|
127 |
6 |
p. 560-564
5 p.
|
artikel
|
| 4 |
Combination warfarin-ASA therapy: Which patients should receive it, which patients should not, and why?
|
Douketis, James D.
|
|
2011
|
127 |
6 |
p. 513-517
5 p.
|
artikel
|
| 5 |
Comparison of the diagnostic performance of the original and modified Wells score in inpatients and outpatients with suspected deep vein thrombosis
|
Engelberger, Rolf P.
|
|
2011
|
127 |
6 |
p. 535-539
5 p.
|
artikel
|
| 6 |
Contribution of Surface Localization to Platelet Activation by CD154 Antibodies and Introduction of a Novel Approach for Studying Immune Complex Activity
|
Hatfield, Meghan
|
|
2011
|
127 |
6 |
p. 571-575
5 p.
|
artikel
|
| 7 |
Editorial Board
|
|
|
2011
|
127 |
6 |
p. IFC-
1 p.
|
artikel
|
| 8 |
Evaluation of anti-platelet and anti-thrombotic effects of cilostazol with PFA-100® and Multiplate® whole blood aggregometer in vitro, ex vivo and FeCl3-induced thrombosis models in vivo
|
Kim, Chae-Wook
|
|
2011
|
127 |
6 |
p. 565-570
6 p.
|
artikel
|
| 9 |
Homocysteinylated fibrinogen forms disulfide-linked complexes with albumin
|
Sauls, Derrick L.
|
|
2011
|
127 |
6 |
p. 576-581
6 p.
|
artikel
|
| 10 |
Increased warfarin consumption and residual fibrin turnover in thrombotic patients with primary antiphospholipid syndrome
|
Ames, Paul R.J.
|
|
2011
|
127 |
6 |
p. 595-599
5 p.
|
artikel
|
| 11 |
Investigation into the mechanism(s) of antithrombotic effects of carbon monoxide releasing molecule-3 (CORM-3)
|
Soni, Hitesh
|
|
2011
|
127 |
6 |
p. 551-559
9 p.
|
artikel
|
| 12 |
In vivo anticoagulant effect of ethyl pyruvate in endotoxemic rats
|
Kung, Ching-Wen
|
|
2011
|
127 |
6 |
p. 582-588
7 p.
|
artikel
|
| 13 |
Mortality and recurrence after treatment of VTE: Long term follow-up of patients with good life-expectancy
|
Andresen, Marianne S.
|
|
2011
|
127 |
6 |
p. 540-546
7 p.
|
artikel
|
| 14 |
New antithrombotics: The impact on global health care
|
Mahan, Charles E.
|
|
2011
|
127 |
6 |
p. 518-524
7 p.
|
artikel
|
| 15 |
No firm association between N-terminal pro-brain natriuretic peptide and percentage of pulmonary vascular obstruction in patients with acute pulmonary embolism
|
Agterof, M.J.
|
|
2011
|
127 |
6 |
p. 547-550
4 p.
|
artikel
|
| 16 |
Standardization of lupus anticoagulant. Feasibility study of a calibration model to minimize between-method variability
|
Tripodi, Armando
|
|
2011
|
127 |
6 |
p. 589-594
6 p.
|
artikel
|
| 17 |
Successful treatment of refractory acute GVHD complicated by severe intestinal transplant-associated thrombotic microangiopathy using recombinant thrombomodulin
|
Inoue, Yasuyuki
|
|
2011
|
127 |
6 |
p. 603-604
2 p.
|
artikel
|
| 18 |
The mechanism of action of rivaroxaban – an oral, direct Factor Xa inhibitor – compared with other anticoagulants
|
Samama, Meyer Michel
|
|
2011
|
127 |
6 |
p. 497-504
8 p.
|
artikel
|
| 19 |
Thrombophilic dimension of Budd chiari syndrome and portal venous thrombosis – A concise review
|
Shetty, Shrimati
|
|
2011
|
127 |
6 |
p. 505-512
8 p.
|
artikel
|
| 20 |
Thromboxane metabolite excretion during pregnancy – influence of preeclampsia and aspirin treatment
|
Perneby, Christina
|
|
2011
|
127 |
6 |
p. 605-606
2 p.
|
artikel
|
| 21 |
Tissue factor as a target for the treatment of disseminated intravascular coagulation
|
Monteiro, Robson Q.
|
|
2011
|
127 |
6 |
p. 495-496
2 p.
|
artikel
|
Tijdschrift beschrijving